{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:11:19Z","timestamp":1769170279503,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.japh.2025.102950","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:08:20Z","timestamp":1761185300000},"page":"102950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing attitudes toward community pharmacy services and a pharmacist\u2019s role in substance use treatment by those utilizing day center and harm reduction services"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8330-068X","authenticated-orcid":false,"given":"Joshua","family":"Knebel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Chapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2025.102950_bib2","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56)","year":"2024"},{"key":"10.1016\/j.japh.2025.102950_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114720","article-title":"Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample","volume":"315","author":"Jegede","year":"2022","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.japh.2025.102950_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1339801","article-title":"A systematic review of approaches to improve medication adherence in homeless adults with psychiatric disorders","volume":"14","author":"Hird","year":"2024","journal-title":"Front Psychiatry"},{"issue":"9","key":"10.1016\/j.japh.2025.102950_bib8","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.2146\/ajhp150542","article-title":"ASHP statement on the pharmacist\u2019s role in substance abuse prevention, education, and assistance","volume":"73","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.japh.2025.102950_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jac5.1768","article-title":"Pharmacist-delivered comprehensive medication management in a substance use disorder clinic, an 18-month descriptive study","volume":"6","author":"Tran","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.japh.2025.102950_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108440","article-title":"Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention","volume":"130","author":"Smith","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.japh.2025.102950_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.japh.2019.11.013","article-title":"Pharmacist impact on health outcomes in a homeless population","volume":"60","author":"Bahrami","year":"2020","journal-title":"J. Am. Pharm. Assoc. (2003)"},{"issue":"1","key":"10.1016\/j.japh.2025.102950_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11096-019-00789-4","article-title":"Perceived roles and barriers in caring for the people who are homeless: a survey of UK community pharmacists","volume":"41","author":"Paudyal","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.japh.2025.102950_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12954-018-0211-4","article-title":"Pharmacists\u2019 role in harm reduction: a survey assessment of Kentucky community pharmacists\u2019 willingness to participate in syringe\/needle exchange","volume":"15","author":"Goodin","year":"2018","journal-title":"Harm Reduct J"},{"issue":"6","key":"10.1016\/j.japh.2025.102950_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.japh.2017.06.017","article-title":"Self-reported participation in voluntary nonprescription syringe sales in California\u2019s Central Valley","volume":"57","author":"Pollini","year":"2017","journal-title":"J Am Pharm Assoc(2003)"},{"key":"10.1016\/j.japh.2025.102950_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2016.06.023","article-title":"Nonprescription syringe sales: resistant pharmacists\u2019 attitudes and practices","volume":"166","author":"Chiarello","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2025.102950_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","article-title":"Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study","volume":"18","author":"Parry","year":"2021","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.japh.2025.102950_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001570","article-title":"A systematic review of evidence on the links between patient experience and clinical safety and effectiveness","volume":"3","author":"Doyle","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.japh.2025.102950_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40271-014-0060-5","article-title":"Measuring patient experience: concepts and methods","volume":"7","author":"Ahmed","year":"2014","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.japh.2025.102950_bib20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12913-024-10971-8","article-title":"A scoping review examining patient experience and what matters to people experiencing homelessness when seeking healthcare","volume":"24","author":"Miller","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.japh.2025.102950_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7517-11-13","article-title":"A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012","volume":"11","author":"Kuo","year":"2014","journal-title":"Harm Reduct J"},{"issue":"6","key":"10.1016\/j.japh.2025.102950_bib22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3122\/jabfm.19.6.542","article-title":"Patient practices and beliefs concerning disposal of medications","volume":"19","author":"Seehusen","year":"2006","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.japh.2025.102950_bib24","series-title":"Research Design, Qualitative, Quantitative, and Mixed Methods Approaches","first-page":"179","article-title":"Qualitative methods","author":"Creswell","year":"2014"},{"issue":"2","key":"10.1016\/j.japh.2025.102950_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4321\/S1886-36552009000200005","article-title":"Provision of clinical pharmacy services in two safety net provider settings","volume":"7","author":"Connor","year":"2009","journal-title":"Pharm. Pract (Granada)"},{"key":"10.1016\/j.japh.2025.102950_bib27","author":"Maxwell"},{"issue":"4","key":"10.1016\/j.japh.2025.102950_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40263-020-00711-x","article-title":"Pharmacological treatment of methamphetamine\/amphetamine dependence: a systematic review","volume":"34","author":"Siefried","year":"2020","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.japh.2025.102950_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.9740\/mhc.2022.08.219","article-title":"Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes","volume":"12","author":"Ehrhard","year":"2022","journal-title":"Ment Health Clin"},{"issue":"suppl 1","key":"10.1016\/j.japh.2025.102950_bib30","first-page":"1","article-title":"The ASAM\/AAAP clinical practice guideline on the management of stimulant use disorder","volume":"18","year":"2024","journal-title":"J Addict Med"},{"key":"10.1016\/j.japh.2025.102950_bib31","article-title":"Implementing an evidence-based prize contingency management protocol for stimulant use","volume":"151","author":"Rash","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"10.1016\/j.japh.2025.102950_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1037\/ccp0000552","article-title":"Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: a meta-analysis","volume":"89","author":"Ginley","year":"2021","journal-title":"J Consult Clin Psychol"},{"issue":"7","key":"10.1016\/j.japh.2025.102950_bib34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamapsychiatry.2024.0426","article-title":"Prevalence of mental health disorders among individuals experiencing homelessness: a systematic review and meta-analysis","volume":"81","author":"Barry","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.japh.2025.102950_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/WNF.0b013e318261e193","article-title":"Co-occurring psychotic and addictive disorders: neurobiology and diagnosis","volume":"35","author":"Ross","year":"2012","journal-title":"Clin Neuropharmacol"},{"issue":"suppl 4","key":"10.1016\/j.japh.2025.102950_bib36","doi-asserted-by":"crossref","first-page":"S494","DOI":"10.4103\/psychiatry.IndianJPsychiatry_18_18","article-title":"Psychosocial interventions in patients with dual diagnosis","volume":"60","author":"Subodh","year":"2018","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.japh.2025.102950_bib37","first-page":"87","article-title":"Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review","volume":"6","author":"Al-Jumah","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.japh.2025.102950_bib38","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.japh.2022.06.009","article-title":"Impact of a pharmacist-led mood stabilizer laboratory monitoring protocol","volume":"62","author":"Horvath","year":"2022","journal-title":"J. Am. Pharm. Assoc. (2003)"},{"issue":"12","key":"10.1016\/j.japh.2025.102950_bib39","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00127-016-1259-7","article-title":"Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study","volume":"51","author":"Rezansoff","year":"2016","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"10.1016\/j.japh.2025.102950_bib40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","article-title":"Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia","volume":"161","author":"Gilmer","year":"2004","journal-title":"Am J Psychiatry"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:53:56Z","timestamp":1769111636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1544319125006296"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102950","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing attitudes toward community pharmacy services and a pharmacist\u2019s role in substance use treatment by those utilizing day center and harm reduction services","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102950"}}